Nexira's Simag ingredient can be formulated into foods, beverages, and dietary supplements.
Because of growing interest in magnesium for overall health, Nexira (Rouen, France) is introducing Simag, a seawater extract rich in magnesium. The ingredient will be showcased at the IFT Food Expo taking place in Chicago in July.
Available data indicates that many consumers are falling short of the Recommended Dietary Allowance (RDA) for magnesium, and Nexira points to a number of health disorders which could be linked to magnesium deficiency, including depression, anxiety, cramps, and cardiovascular disorders. Simag’s potential target markets include children and teenagers (for bones and teeth); pregnant and lactating women (magnesium supplements are often recommended for this population); sports nutrition; and stress and sleep arenas.
At 15–55% magnesium, a Simag format is available for foods, beverages, tablets, and capsules. The seawater extract is produced without synthetic solvents, and Nexira lowers the ingredient’s natural sodium and chloride contents during processing. Magnesium claims such as “source of magnesium” and “rich in magnesium” are possible with the extract.
Nutritional Outlook's Women in Nutraceuticals Roundtable: The Future of Women's Health Research
July 19th 2024Watch "The Future of Women's Health Research," a roundtable discussion presented by Nutritional Outlook in partnership with Women in Nutraceuticals. This roundtable is supplement to a recent article commissioned by WIN and published by Nutritional Outlook, titled “Taking Initiative: Can the WHI’s model help the nutraceutical industry answer questions the study didn’t even ask?”
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.